PharmaPharma Ltd.

Infectious Disease Small Molecule Development Partnership

The client required rapid scale-up of their Infectious Disease therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Rare Disease Small Molecule Development Partnership

The client required rapid scale-up of their Rare Disease therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Oncology Small Molecule Development Partnership

The client required rapid scale-up of their Oncology therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Accelerated Development of COVID-19 Vaccine

The client required rapid scale-up while maintaining strict quality standards and regulatory compliance. Time-to-market was critical.

Our team implemented innovative process optimization techniques, leveraged advanced manufacturing technologies, and established robust quality control systems.

Project completed 30% faster than industry average with zero quality deviations. Client achieved regulatory approval on first submission.